These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3814927)

  • 1. Significance of positive and negative syndromes in chronic schizophrenia.
    Kay SR; Opler LA; Fiszbein A
    Br J Psychiatry; 1986 Oct; 149():439-48. PubMed ID: 3814927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative syndromes in chronic schizophrenic inpatients.
    Opler LA; Kay SR; Rosado V; Lindenmayer JP
    J Nerv Ment Dis; 1984 Jun; 172(6):317-25. PubMed ID: 6152720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the positive and negative syndrome scale for schizophrenics.
    Kay SR; Opler LA; Lindenmayer JP
    Psychiatry Res; 1988 Jan; 23(1):99-110. PubMed ID: 3363019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positive and negative syndrome scale (PANSS) for schizophrenia.
    Kay SR; Fiszbein A; Opler LA
    Schizophr Bull; 1987; 13(2):261-76. PubMed ID: 3616518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The positive-negative dimension in schizophrenia: its validity and significance.
    Kay SR; Opler LA
    Psychiatr Dev; 1987; 5(2):79-103. PubMed ID: 2888108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition of the negative syndrome of chronic schizophrenia.
    Kibel DA; Laffont I; Liddle PF
    Br J Psychiatry; 1993 Jun; 162():744-50. PubMed ID: 8330105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of positive and negative schizophrenic syndromes in Nigerian patients.
    Gureje O
    Br J Psychiatry; 1989 Nov; 155():628-32. PubMed ID: 2575423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.
    Malaspina D; Goetz RR; Yale S; Berman A; Friedman JH; Tremeau F; Printz D; Amador X; Johnson J; Brown A; Gorman JM
    Am J Psychiatry; 2000 Jun; 157(6):994-1003. PubMed ID: 10831482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive:negative dichotomy in schizophrenia.
    Mortimer AM; Lund CE; McKenna PJ
    Br J Psychiatry; 1990 Jul; 157():41-9. PubMed ID: 2397361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight, neurocognitive function and symptom clusters in chronic schizophrenia.
    Collins AA; Remington GJ; Coulter K; Birkett K
    Schizophr Res; 1997 Oct; 27(1):37-44. PubMed ID: 9373893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.